CAS 1266684-01-8

FIDAS-3

CAS : 1266684-01-8

FIDAS-3, a stilbene derivative and potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A), exhibits anticancer activities

Formule : C₁₆H₁₅F₂N

Degré de pureté : 97.75%

Couleur et forme : Solid

Masse moléculaire : 259.29

Ref: TM-T11284

(E)-4-(2,6-Difluorostyryl)-N,N-dimethylaniline

CAS : 1266684-01-8

Formule : C₁₆H₁₅F₂N

Degré de pureté : 99.12%

Couleur et forme : Solid

Masse moléculaire : 259.2938

Ref: IN-DA01X0SC

FIDAS-3

CAS : 1266684-01-8

FIDAS-3

Degré de pureté : ≥95%

Masse moléculaire : 259.29g/mol

Ref: 54-BUP15615

FIDAS-3

CAS : 1266684-01-8

FIDAS-3 is an anticancer drug that has been developed as a kinase inhibitor analog of artesunate. It has been shown to be effective in inducing apoptosis in human cancer cells. FIDAS-3 targets kinases that are involved in cell proliferation and survival, leading to the inhibition of tumor growth. This drug has been tested on Chinese hamster ovary cells and human lung cancer cells, showing potent antitumor activity. FIDAS-3 can be detected in urine after administration, making it a promising candidate for clinical trials. The combination of FIDAS-3 with chloroquine has also been shown to increase its anticancer effects by inhibiting autophagy. Overall, FIDAS-3 is a promising new drug for the treatment of cancer that shows great potential for further development.

Formule : C₁₆H₁₅F₂N

Degré de pureté : Min. 95%

Masse moléculaire : 259.29 g/mol

Ref: 3D-RAC68401